Menu Search
Equities

Medinotec Inc

MDNC:QXR

Medinotec Inc

Actions
  • Price (USD)5.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 14 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Medinotec Inc had net income fall 14.73% from a loss of 352.74k to a larger loss of 404.69k despite a 402.25% increase in revenues from 999.58k to 5.02m. An increase in the cost of goods sold as a percentage of sales from 41.79% to 51.35% was a component in the falling net income despite rising revenues.
Gross margin44.05%
Net profit margin-4.90%
Operating margin2.51%
Return on assets-7.54%
Return on equity-13.94%
Return on investment-8.32%
More ▼

Cash flow in USDView more

In 2024, Medinotec Inc did not generate a significant amount of cash. However, the company earned 14.24k from its operations for a Cash Flow Margin of 0.28%. In addition the company generated 10.13k cash from investing, though they paid out 8.09k more in financing than they received.
Cash flow per share-0.021
Price/Cash flow per share--
Book value per share0.1918
Tangible book value per share0.1918
More ▼

Balance sheet in USDView more

Medinotec Inc appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio5.10
Quick ratio3.86
Total debt/total equity0.5628
Total debt/total capital0.3601
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.